To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma

Conditions: Melanoma Stage III; Melanoma Stage IV; Melanoma Interventions: Biological: ADP-TILIL7; Drug: Cyclophosphamide; Drug: Fludarabine Phosphate; Drug: Proleukin Sponsors: Inge Marie Svane; Adaptimmune Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials